Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 164

The DOI matches its Crossref record.

Molecular and Cellular Aspects of Carcinogen Screening Tests

Open access
Fox, M·1981·British Journal of Cancer

Abstract

review of infectious complications of malignant disease and in the treatment of malignant disease. This is thorough and the different infections are arranged to stress their relevant importance. The self-assessment questions are comprehensive and, in most cases, pose valid and relevant questions. Some questions, however, do not appear to have a definite answer, and it is to be hoped that the American Sub-specialty Boards allow for discussion of controversies in medical oncology in which a simple true-or-false or multiple-choice answer is inappropriate. In summary, this book represents a massive accumulation of data and information. It cannot, however, be fully recommended, because of its, at times, incomprehensible style and its lack of space to discuss objectively different treatment options available for many of the diseases in which chemotherapy is used. Some of the newer information on responses of a variety of short-term tests to mutagens and carcinogens are presented in this volume, and it is evident that a more critical and analytical approach to the vast amount of data being generated is now being adopted. Much more emphasis is now being placed on understanding the scientific basis for the various short-term tests. There is also a shift of emphasis from an exclusive consideration of tests which will detect only initiators to those which will detect promoters and will respond to epigenetic effects now being reconsidered as possibly involved in carcino-genesis; this new approach being exemplified by the contribution from Radman and his co-workers. The interesting section on the scientific basis for short-term tests includes a pertinent paper from Green (Sussex) in which the problems of using the Ames test as even a qualitative index of carcinogenicity are discussed; the main problem being how to define a positive result. When attempts are made to use even the well-validated Ames test quantitatively (i.e. to attempt correlations of muta-genic potency with carcinogenic potency) the problems are compounded, and these are lucidly discussed in this paper. Other papers in the volume deal with inter-laboratory reproducibility of various tests, attempts at a classification of experimental evidence to indicate degrees of carcinogeni-city, and details of various international collaborative schemes for mutagenicity and carcinogenicity. Overall, a useful update of progress in this rapidly expanding field. In the last decade, there has been evidence of a gradual reduction in deaths due to cancer in the under-45 age group. This decrease in the younger age group can be in part …

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/bjc.1981.40

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 164

Metadata

Authors
Fox, M.
Venue
British Journal of Cancer
Published
1981-02-01
Volume
43
Issue
2
Pages
250-250
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2071473402
Cited by
164
References
0
Type
book review
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Molecular and Cellular Aspects of Carcinogen Screening Tests. https://app.cochat.ai/papers/10.1038/bjc.1981.40
The paper
Fox, M. (1981). Molecular and Cellular Aspects of Carcinogen Screening Tests. British Journal of Cancer. https://doi.org/10.1038/bjc.1981.40

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.